PRELUDE CAPITAL MANAGEMENT, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 72 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 1.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2015$88,000
+528.6%
617
+517.0%
0.01%
+550.0%
Q2 2015$14,000
-53.3%
100
-50.0%
0.00%
-50.0%
Q4 2014$30,000
-63.9%
200
-66.3%
0.00%
-63.6%
Q2 2014$83,0005940.01%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q2 2014
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders